Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-003976
Filing Date
2017-04-17
Accepted
2017-04-17 12:57:47
Documents
47
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 837888
2 ex10-17.htm EX-10.17 1366
3 ex10-18.htm EX-10.18 1387
4 ex31-1.htm EX-31.1 16855
5 ex31-2.htm EX-31.2 15661
6 ex32-1.htm EX-32.1 8092
7 image_001.jpg GRAPHIC 3741
8 image_002.jpg GRAPHIC 289508
9 image_003.jpg GRAPHIC 136994
  Complete submission text file 0001493152-17-003976.txt   2693596

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE vapa-20161231.xml EX-101.INS 142807
11 XBRL SCHEMA FILE vapa-20161231.xsd EX-101.SCH 19479
12 XBRL CALCULATION FILE vapa-20161231_cal.xml EX-101.CAL 27699
13 XBRL DEFINITION FILE vapa-20161231_def.xml EX-101.DEF 80202
14 XBRL LABEL FILE vapa-20161231_lab.xml EX-101.LAB 153353
15 XBRL PRESENTATION FILE vapa-20161231_pre.xml EX-101.PRE 130548
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55470 | Film No.: 17764068
SIC: 2834 Pharmaceutical Preparations